Innovaderm is thrilled to announce that it’s Chief Medical Officer, Dr. Jasmina Jankicevic, will be chairing Pharmaceutical Business Conference Group‘s (PBC Group) Clinical Outsourcing Group: CRO Summit on December 3rd & 4th, 2024.
The Future of Clinical Research: Summit Chair Jasmina Jankicevic Weighs in on CRO Evolution – Read the interview now to learn on the changing environment for clinical research, and adapting role of CROs.
Proud member of the PBC Group advisory board, Dr. Jankicevic will be leading several discussions and sessions during the annual event:
- Harnessing CRO’s Therapeutic Expertise to Accelerate Trial Delivery
CROs possess invaluable internal therapeutic area expertise that can significantly accelerate trial delivery when effectively utilized. Exploring how sponsors can leverage their CRO’s therapeutic lead to identify key opinion leaders, select the most suitable clinical trial sites, and determine the optimal geography for trial launch.
In this session, Jasmina will discuss strategies for maximizing the impact of therapeutic expertise, enhancing decision-making processes, and ultimately accelerating the delivery of clinical trials. Bridging the gap between CRO knowledge and execution to achieve optimal results.
- Navigating the Future: Strategic Outlook for the CRO Industry
The biopharma landscape is experiencing unprecedented changes, driven by technological advancements, evolving funding models, and shifting healthcare dynamics. CROs are challenged to adapt their strategies to these transformative forces while continuing to deliver innovative therapies and value to patients.
In this session, the panel of CRO executives will examine the impact of AI, discuss emerging funding and payment models, consider the expanding role of pharmacies in trial delivery, and analyze industry-wide consolidation trends. The panel will also explore how these impactful changes are reshaping the landscape for trial delivery.
